Umesh Bhatt

Umesh Bhatt leads bispecific antibody chemistry and formulation development at AbbVie, optimizing the pharmaceutical properties of novel bispecific and multispecific antibody formats for clinical development. His work on dual variable domain immunoglobulin technology and other bispecific formats has addressed key CMC challenges including protein stability, aggregation, and manufacturability. He has contributed to advancing multiple bispecific antibody candidates through the chemistry, manufacturing, and controls requirements for clinical and commercial development.